EMA European Medicines Agency
Trending Articles
Related Content
Regulatory
EMA phases out extraordinary COVID-19 regulatory flexibilities
EMA, the European Commission (EC) and the Heads of Medicines Agencies (HMA) have announced that flexibilities on pharmaceutical manufacturing aspects, such as manufacturing and importation of active pharmaceutical ingredients and finished products and quality variations, have ended